Skip to content

Pulsed electromagnetic fields(PEMFs) for postmenopausal osteoporosis and concomitant lumbar osteoarthritis

Pulsed electromagnetic fields(PEMFs) for postmenopausal osteoporosis and concomitant lumbar osteoarthritis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14005156
Enrollment
Unknown
Registered
2014-08-25
Start date
2015-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postmenopausal Osteoporosis, Lumbar Osteoarthritis

Interventions

PEMFs:PEMFs + Usual care
sham PEMFs:sham PEMFs + Usual care

Sponsors

Department of Rehabilitation Medicine, West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
50 Years to 70 Years

Inclusion criteria

Inclusion criteria: To be eligible, participants should meet the following criteria: 1. postmenopausal women; 2. aged between 50 and 70 years; 3. who had been postmenopausal for at least 5 year and diagnosed with OP (femur T-score of -2.5 or less); 4. with concomitant lumbar osteoarthritis.

Exclusion criteria

Exclusion criteria: Women suffering from suspected confounding disorders (e.g., diabetes mellitus, hypertension, hyperlipidemia, obesity, secondary and idiopathic osteoporosis, fracture history, systemic inflammatory disorders, visual impairment, severe vestibular lesions, cerebellar lesions, peripheral nerve or muscle disease, mental retardation, mental illness, cognitive impairment, obstetrical and gynecological diseases, blood disease, stroke or venous thromboembolic disease, thyroid, parathyroid, adrenal, hepatic and renal disease, malignancy, etc.), who had received anti-osteoporosis treatment within 6 months before inclusion, and those not suitable to be included for any other reason not mentioned above will all be excluded. For lumbar osteoarthritis, further exclusion criteria are: 1. Congenital spinal diseases; 2. Scoliosis; 3. Spondylolisthesis - Spondylolysis; 4. Vertebral fracture; 5. History of spinal surgery; 6. Inflammatory arthropathy; 7. Individuals who have had facet joint injection or any physical therapy (for example, chiropractic, osteopathy or physiotherapy treatment) for back pain in the previous 6 months and with contraindications to receive the proposed treatment and assessments; 8. Patients with brachialgia and pure cervical disk herniation diagnosed by physical examination and CT or MRI.

Design outcomes

Primary

MeasureTime frame
proximal femur bone mineral density;

Secondary

MeasureTime frame
Visual Analogue Scale;Oswestry Disability Index (ODI);bone mineral density of the lumbar spine;Serum 25OH vitamin D3 (25(OH) D) concentrations;Hemorheological determinants;Manual muscle test (MMT) score;Berg Balance Scale (BBS) score;Timed Up & Go Test (TUG);Range of Motion of lumbar spine;Overall functional ability using SF-36;Health care consumption costs;Compliance;Bone metabolism index;

Countries

China

Contacts

Public ContactHe Cheng-qi
chengqi.he3477@gmail.com+86-028-85422847

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 4, 2026